Drugs (Pharmaceuticals) – Page 16

With Cyberattack Fix Weeks Away, Health Providers Slam United

Hospitals, doctors and clinics expressed frustration that they will have to wait even longer for reimbursements after hackers paralyzed the largest U.S. billing clearinghouse.

By Reed Abelson and Julie Creswell

Clinical Trials Cohen, Joshua B Drugs (Pharmaceuticals) Food and Drug Administration Klee, Justin United States

A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market

Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks.

By Pam Belluck

donanemab Drugs (Pharmaceuticals) Eli Lilly and Company Food and Drug Administration

F.D.A. Delays Action on Closely Watched Alzheimer’s Drug

Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.

By Pam Belluck

Chemotherapy Cyberattacks and Hackers Cyberwarfare and Defense Doctors Drugs (Pharmaceuticals) Drugstores Finances Health and Human Services Department Health Insurance and Managed Care Hospitals Medicare Politics and Government Schumer, Charles E United States Politics and Government

Cyberattack Wreaks Havoc on Health Care Billing

The hack shut down the nation’s biggest health care payment system, causing financial chaos affecting a broad spectrum ranging from large hospitals to single-doctor practices.

By Reed Abelson and Julie Creswell

mosaec